Additional file 2: Figure S3. of New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies SehrT. ProschmannU. ThomasK. MarggrafM. StraubeE. ReichmannH. ChanA. ZiemssenT. 2016 Correlation of pre- and post-serum values at both timepoints. Correlation of pre- (black circle) and post- (white circle) NAT serum values at timepoint 0 and after 1 year (+1a). r = Spearman’s rank correlation coefficient, p = p value of significance. (PPTX 45 kb)